About Conference
This symposium is presented by the Michigan Medicine Rogel Cancer Center (UMRCC). After this activity, participants will be able to utilize the current state-of-the-art updates in the diagnosis, risk stratification, and treatment of advanced genitourinary cancers including prostate, renal, bladder, and testis. They'll also be able to access information and enroll advanced genitourinary cancer patients in current state-of-the-art, groundbreaking clinical trials at Michigan Medicine
Highlights
The Michigan Medicine Rogel Cancer Center (UMRCC) is an NCI-designated comprehensive cancer center with a history of excellence in cancer care, education, and research
Find on Map
Recommended News For You
Recommended Articles For You
Featured News
Featured Articles
Featured Events
Featured KOL Videos
1.
Stem Cell Selection Unneeded for SSc Transplant Therapy?
2.
Lung Transplant for Lung Cancer: Promising, in Rare Cases
3.
Rural-urban disparities seen in cervical cancer
4.
Obesity linked to subsequent neoplasms in childhood cancer survivors
5.
New policy review highlights the importance of health-related quality of life in advanced cancer
1.
Empowering Oncology with Data: Cloud Security, Real-World Evidence, and Clinical Insights
2.
Transplant Oncology and Anti-Cancer Immunosuppressants: The Evolution of a Paradigm in Cancer Care
3.
Is AI The New Radiologist For Breast MRI?
4.
Pediatric Oncology at the Cutting Edge: From Early Diagnosis to Lifesaving Therapies
5.
Bone Marrow Regeneration in Hematologic Recovery
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Navigating the Complexities of Ph Negative ALL - Part VI
2.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
3.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III
4.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VI
Recommended News For You
1.
Checking PSA levels too soon after prostate cancer surgery can lead to overtreatment, study suggests
2.
Child Death Rates Are Rising in the U. s. ; Water Beads Warning; Cancer Studies Retracted.
3.
Pollution exposure may affect lung cancer in women who have never smoked
4.
What Dolph Lundgren's journey from terminal diagnosis to 'cancer free' can tell us about cancer care
5.
Study finds 81% of cancer cures touted by TikTok videos are fake
Conferences That Might Interest You
Recommended Articles For You
1.
Understanding Macrocytosis: Causes, Symptoms, and Treatment Options
2.
The Converging Frontiers of Radiation Oncology and Systemic Therapies by 2025
3.
Targeted Approaches to Breast Cancer Liver Metastases: Surgery, Ablation, and Survival Insights
4.
The Risk Factors of Venous Thromboembolism and How to Lower Your Chances
5.
The Importance of Early Detection in Skin Cancer: Why Regular Skin Exams Matter
Boost Your Knowledge With These Quizzes
1.
Quiz on Sebaceous Dermatitis, Causes, Symptoms and Treatment Options
2.
Quiz on Hormonal Harmony: Mastering Endocrine Aspects of Gender Affirming Care
3.
Quiz on Novel Therapies for Heart Failure
4.
Quiz On Celiac Disease Patient Management
5.
Quiz on Wearable Endocrinology: Redefining Hormone Care with Technology
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Welcome to Hidoc Dr.
Join to enhance your clinical skills and gain specialized in-depth medical knowledge